TY - JOUR
T1 - Predicting short- to long-term breast cancer risk from longitudinal mammographic screening history
AU - Wang, Xin
AU - Tan, Tao
AU - Gao, Yuan
AU - Su, Ruisheng
AU - Teuwen, Jonas
AU - Kroes, Jaap
AU - Zhang, Tianyu
AU - D’Angelo, Anna
AU - Han, Luyi
AU - Drukker, Caroline A.
AU - Schmidt, Marjanka K.
AU - Beets-Tan, Regina
AU - Karssemeijer, Nico
AU - Mann, Ritse
N1 - Publisher Copyright:
© The Author(s) 2025.
PY - 2025/12
Y1 - 2025/12
N2 - Breast cancer (BC) risk assessment aims to enhance individualized screening and prevention strategies. While recent deep learning (DL) models based on mammography have shown promise in short-term risk prediction, they primarily rely on single-time-point (STP) exams, ignoring temporal changes in breast tissue from sequence exams. We present the Multi-Time Point Breast Cancer Risk Model (MTP-BCR), a novel DL approach that integrates traditional risk factors and longitudinal mammography data to capture subtle tissue changes indicative of future malignancy. Using a large in-house dataset with 171,168 mammograms from 9133 women, MTP-BCR achieved superior performance in 10-year risk prediction, with an AUC of 0.80 (95% CI, 0.78–0.82) at the patient level, outperforming STP-based and traditional risk models. External validation on the CSAW-CC dataset confirmed its robustness. Further analysis demonstrates the advantages of the MTP-BCR method in diverse populations. MTP-BCR also excels in risk stratification and offers heatmaps to enhance clinical interpretability.
AB - Breast cancer (BC) risk assessment aims to enhance individualized screening and prevention strategies. While recent deep learning (DL) models based on mammography have shown promise in short-term risk prediction, they primarily rely on single-time-point (STP) exams, ignoring temporal changes in breast tissue from sequence exams. We present the Multi-Time Point Breast Cancer Risk Model (MTP-BCR), a novel DL approach that integrates traditional risk factors and longitudinal mammography data to capture subtle tissue changes indicative of future malignancy. Using a large in-house dataset with 171,168 mammograms from 9133 women, MTP-BCR achieved superior performance in 10-year risk prediction, with an AUC of 0.80 (95% CI, 0.78–0.82) at the patient level, outperforming STP-based and traditional risk models. External validation on the CSAW-CC dataset confirmed its robustness. Further analysis demonstrates the advantages of the MTP-BCR method in diverse populations. MTP-BCR also excels in risk stratification and offers heatmaps to enhance clinical interpretability.
UR - https://www.scopus.com/pages/publications/105020309966
U2 - 10.1038/s41523-025-00831-x
DO - 10.1038/s41523-025-00831-x
M3 - Article
AN - SCOPUS:105020309966
SN - 2374-4677
VL - 11
JO - npj Breast Cancer
JF - npj Breast Cancer
IS - 1
M1 - 118
ER -